Suppr超能文献

门诊美沙酮维持治疗的效果。 (注:原文中buprenorphine是丁丙诺啡,这里翻译为美沙酮可能有误,正确翻译应该是“丁丙诺啡维持治疗在门诊实践中的结果” )

Outcomes of buprenorphine maintenance in office-based practice.

作者信息

Magura Stephen, Lee Stephen J, Salsitz Edwin A, Kolodny Andrew, Whitley Susan D, Taubes Tanaquil, Seewald Randy, Joseph Herman, Kayman Deborah J, Fong Chunki, Marsch Lisa A, Rosenblum Andrew

机构信息

National Development and Research Institutes, NY 10010, USA.

出版信息

J Addict Dis. 2007;26(2):13-23. doi: 10.1300/J069v26n02_03.

Abstract

Buprenorphine is an efficacious treatment for opioid dependence recently approved for office-based medical practice. The purpose of the study was to describe the background characteristics, treatment process, outcomes and correlates of outcomes for patients receiving buprenorphine maintenance in "real world" office-based settings in New York City, without employing the many patient exclusion criteria characterizing clinical research studies of buprenorphine, including absence of co-occurring psychiatric and non-opioid substance use disorders. A convenience sample of six physicians completed anonymous chart abstraction forms for all patients who began buprenorphine induction or who transferred to these practices during 2003-2005 (N = 86). The endpoint was the patient's current status or status at discharge from the index practice, presented in an intent-to-treat analysis. The results were: male (74%); median age (38 yrs); White, non-Hispanic (82%); employed full-time, (58%); HCV+ (15%); substance use at intake: prescription opioids (50%), heroin (35%), non-opioids (49%); median length of treatment (8 months); median maintenance dose (15 mg/day); prescribed psychiatric medication (63%). The most frequent psychiatric disorders were: major depression, obsessive-compulsive and other anxiety, bipolar. At the endpoint: retained in the index practice (55%); transferred to other buprenorphine practice (6%); transferred to other treatment (7%); lost to contact or out of any treatment (32%). Outcomes were positive, in that 2/3 of patients remained in the index practice or transferred to other treatment. Patients living in their own home or misusing prescription opioids (rather than heroin) were more likely, and those employed part-time were less likely, to be retained in the index practice. At the endpoint, 24% of patients were misusing drugs or alcohol. Co-occurring psychiatric disorders and polysubstance abuse at intake were common, but received clinical attention, which may explain why their effect on outcomes was minimal.

摘要

丁丙诺啡是一种用于治疗阿片类药物依赖的有效药物,最近已被批准用于门诊医疗实践。本研究的目的是描述在纽约市“真实世界”的门诊环境中接受丁丙诺啡维持治疗的患者的背景特征、治疗过程、结局以及结局的相关因素,研究未采用许多在丁丙诺啡临床研究中作为特征的患者排除标准,包括不存在共病的精神疾病和非阿片类物质使用障碍。一个由六名医生组成的便利样本,为所有在2003年至2005年期间开始丁丙诺啡诱导治疗或转至这些医疗机构的患者填写了匿名病历摘要表格(N = 86)。终点是患者在索引医疗机构的当前状态或出院时的状态,以意向性分析呈现。结果如下:男性(74%);年龄中位数(38岁);非西班牙裔白人(82%);全职工作(58%);丙肝病毒阳性(15%);入院时物质使用情况:处方阿片类药物(50%)、海洛因(35%)、非阿片类物质(49%);治疗时间中位数(8个月);维持剂量中位数(15毫克/天);开具精神科药物(63%)。最常见的精神疾病是:重度抑郁症、强迫症和其他焦虑症、双相情感障碍。在终点时:留在索引医疗机构(55%);转至其他丁丙诺啡治疗机构(6%);转至其他治疗(7%);失访或未接受任何治疗(32%)。结局是积极的,因为三分之二的患者留在了索引医疗机构或转至其他治疗。居住在自己家中或滥用处方阿片类药物(而非海洛因)的患者更有可能留在索引医疗机构,而兼职工作的患者留在索引医疗机构的可能性较小。在终点时,24%的患者仍在滥用药物或酒精。入院时共病的精神疾病和多物质滥用很常见,但得到了临床关注,这可能解释了为什么它们对结局的影响最小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验